Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 5:25 PM
Ignite Modification Date:
2025-12-24 @ 5:25 PM
NCT ID:
NCT00738868
Eligibility Criteria:
DISEASE CHARACTERISTICS:
* Histologically confirmed squamous cell carcinoma of the head and neck
* Unresectable disease
* Recurrent disease
* No metastatic disease
* Disease in previously irradiated area must be proven by biopsy or imaging
* At least 3 months between prior radiotherapy and diagnosis of recurrent disease
* Surgery or brachytherapy must be possible
* Measurable or evaluable disease by RECIST criteria
* No available curative therapy
PATIENT CHARACTERISTICS:
* Karnofsky performance status 60-100%
* Not pregnant or nursing
* No psychological, familial, social, or geographical reasons that would make monitoring the patient impossible
* No other malignant disease
PRIOR CONCURRENT THERAPY:
* See Disease Characteristics
* No concurrent participation in another clinical study of an experimental drug
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00738868
Study Brief:
Protocol Section:
NCT00738868